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Abstract 
DNA double-strand break (DSB) repair and checkpoint control represent distinct mechanisms 
to reduce chromosomal instability. Ataxia telangiectasia (A-T) cells have checkpoint arrest 
and DSB repair defects. Here, we examine the efficiency and interplay of ATM’s G2 
checkpoint and repair functions. Artemis cells manifest an identical and epistatic repair defect 
to A-T but show proficient checkpoint responses. Only a few G2 cells enter mitosis within 4 h 
following irradiation with 1 Gy but manifest multiple chromosome breaks. Most checkpoint-
proficient cells arrest at the G2/M checkpoint, with the length of arrest being dependent upon 
the repair capacity. Strikingly, cells released from checkpoint arrest display 1-2 chromosome 
breaks. This represents a major contribution to chromosome breakage. The presence of 
chromosome breaks in cells released from checkpoint arrest suggests that release occurs prior 
to the completion of DSB repair. Strikingly, we show that checkpoint release occurs at a point 
when ~3-4 premature chromosome condensation (PCC) breaks and ~20 gH2AX foci remain. 
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Introduction 
DNA damage response mechanisms function to maintain genomic stability in normal cells. 
Since genomic instability is a characteristic of cancer cells, it is evident that at least some of 
these damage response pathways become impaired during progression to carcinogenesis. 
Additionally, patients with defective damage response pathways frequently show cancer 
predisposition, of which ataxia telangiectasia (A-T) is a well-known example. Significant 
insight has been gained into the roles of individual damage response pathways. Understanding 
the efficiency as well as the interplay between them is an important next step (Difilippantonio 
et al., 2000; Gao et al., 2000). 
DNA double-strand break (DSB) repair and cell cycle checkpoint arrest represent two 
pathways to maintain genomic stability (Wahl and Carr, 2001; van Gent et al., 2001; Lieber et 
al., 2003; Kruhlak et al., 2006; Bekker-Jensen et al., 2006; Mari et al., 2006). Ataxia 
telangiectasia mutated (ATM) plays a critical role in regulating cell cycle checkpoint arrest in 
response to DSBs (Shiloh, 2003; Ward and Chen, 2004; Lou et al., 2006) and also regulates a 
component of DSB repair (Kühne et al., 2004; Riballo et al., 2004). The prevailing evidence 
suggests that in G0/G1 ATM is required for Artemis, a nuclease, to process a subset (~15%) 
of radiation-induced DSBs prior to rejoining. A-T, a disorder caused by mutations in ATM, is 
associated with pronounced chromosomal instability, cancer susceptibility, and clinical 
radiosensitivity. This has generally been attributed to ATM’s role in cell cycle checkpoint 
regulation. However, older cytogenetic data (Cornforth and Bedford, 1985; Jeggo et al., 1998) 
and the recent repair defect described in A-T cells (Riballo et al., 2004) raises the issue of 
how ATM’s repair and checkpoint functions interplay to maintain chromosome stability. 
Here, we exploit A-T as a model to define the efficiency and dissect the interplay between 
DNA repair and cell cycle checkpoint pathways, focusing our attention on two ATM 
dependent functions; DSB repair in G2 and G2/M checkpoint arrest. 
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Results and discussion 
ATM and Artemis dependent DSB repair operates in G1 and G2 
To investigate the contribution of ATM and Artemis to DSB repair in cell cycle phases other 
than G0, we analysed asynchronously growing cell cultures to avoid the potential introduction 
of DSBs during synchronisation. In one approach, we used pan-nuclear centromere protein F 
(CENP-F) staining to identify G2 cells (Liao et al., 1995; Kao et al., 2001) (Suppl. Fig. 1A) 
and added aphidicolin to prevent S phase cells progressing into G2 during analysis. Mitotic 
cells exhibiting distinct centromeric CENP-F staining and condensed chromatin were 
excluded from analysis. Under these conditions, S-phase cells do not progress into G2 (Suppl. 
Fig. 1B) and a considerable proportion of cells irradiated with 1.5 Gy X-rays remain positive 
for pan-nuclear CENP-F staining for 6-8 h (ie they remain in G2), providing sufficient time to 
detect the ATM/Artemis repair defect which is measurable at >4 h post irradiation in G0 cells. 
Enumeration of gH2AX foci in aphidicolin treated, CENP-F positive primary human 
fibroblasts following 1.5 Gy X-irradiation demonstrated that ATM and Artemis dependent 
DSB repair operates in G2 (Fig. 1A). Aphidicolin treatment did not affect the repair capacity 
of G2 cells (Suppl. Fig. 1C) but caused pronounced H2AX phosphorylation in cells that were 
CENP-F negative but positive for the S/G2 marker, CyclinA, most likely due to the activation 
of ATR following replication arrest (Suppl. Fig. 1A). Enumeration of gH2AX foci in CENP-F 
negative cells which were also negative for the pronounced, aphidicolin-induced gH2AX 
phosphorylation allowed the analysis of repair in G1-phase cells (Fig. 1A). For all cell lines, 
we observed similar kinetics and magnitude of repair in G1 and G2, which was also similar to 
that previously observed in G0 cells (Riballo et al., 2004). Foci numbers correlated with DNA 
content being twice as high in G2 compared with G1 (Fig. 1A). In analogy to our previous 
study (Riballo et al., 2004), we confirmed that ATM and Artemis operate in the same repair 
pathway by analysing the repair defect in Artemis cells treated with the specific ATM small 
molecule inhibitor KU55933 (Hickson et al., 2004). The dual deficiency in Artemis and ATM 
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did not cause an increased repair defect relative to the defect in Artemis cells (Fig. 1B). Thus, 
ATM and Artemis are epistatic in G1 and G2, and function to repair a subfraction of DSBs 
similar to that observed in confluent cells. Since our results were obtained with non-isogenic 
human cell lines, we also investigated gH2AX foci formation in matching wild type (WT), A-
T and Artemis mouse embryonic fibroblasts (MEFs) using similar procedures to those 
employed with human cells and observed identical repair kinetics (Suppl. Fig. 1D). 
 To substantiate that gH2AX foci analysis monitors DSB repair, we developed and 
applied a pulsed-field gel electrophoresis (PFGE) technique to monitor DSB repair 
specifically in G2-phase cells (Fig. 1C). Exponentially growing primary human fibroblasts 
were pulse-labeled with [methyl-3H]thymidine for 1 h and irradiated with 80 Gy 4 h after 
labeling (when in G2 (see below)). Following 48 and 72 h of repair, cells were harvested and 
the fraction of radioactivity released from the gel plug into the gel (the “FAR value”) was 
quantified by liquid scintillation counting. The FAR values after repair incubation provide an 
estimate of the level of unrepaired DSBs and can be compared to FAR values obtained from 
samples analysed immediately after irradiation without repair. FACS analysis of parallel 
samples labeled with BrdU instead of [methyl-3H]thymidine showed that labeled cells have 
progressed to late S/G2 at the time of irradiation (4 h after labeling) and remained in G2 for at 
least 72 h after irradiation with 80 Gy (Suppl. Fig. 1E). We obtained a similar level of 
unrepaired DSBs in A-T and Artemis cells which was similar to (or slightly higher than) the 
level of DSBs induced in cells irradiated with 10 Gy and not incubated for repair (ie about 1/8 
of the DSBs induced by 80 Gy remain unrepaired) (Fig. 1C). Thus, the magnitude of the G2 
repair defect measured by PFGE is similar to the ~15% repair defect observed by gH2AX foci 
analysis of G2 or G1 cells (Fig. 1A) and confluent cells (Riballo et al., 2004). The identical 
repair defect of A-T and Artemis cells in G2 and G1 is perhaps surprising given that ATM has 
been reported to be required for homologous recombination. One possible explanation is that 
Artemis has a role in DSB repair processes other than non-homologous end joining. 
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Alternatively, our findings could indicate that the majority of IR-induced DSBs are repaired 
by non-homologous end joining in G1 and G2. In support of this, we have observed that DNA 
ligase IV- and Ku80-deficient MEFs have a similar, major DSB repair defect in G1 and G2 
(data not shown). 
 
Artemis cells show normal checkpoint induction and prolonged G2/M arrest 
Previously, we presented evidence that Artemis cells show normal G2/M checkpoint 
activation assessed by counting mitotic cells up to 9 h post ionising radiation (IR) (Riballo et 
al., 2004). Subsequently, Zhang et al. (2004) using phosphoH3 FACS analysis concluded that 
cells treated with Artemis siRNA show premature release from the G2/M checkpoint, 
implicating Artemis in IR-induced checkpoint responses. To examine the maintenance as well 
as the activation of G2/M arrest, we counted mitotic cells up to 24 h post IR in cells treated 
with nocodazole to accumulate cells in mitosis. We confirm that Artemis cells, in contrast to 
A-T cells, show normal G2/M checkpoint induction and, importantly, maintain arrested for 
the same length and possibly greater than WT cells (Suppl. Fig. 2A). 
We next analysed the G2/M checkpoint by phosphoH3 FACS analysis and observed 
checkpoint activation in Artemis but not A-T cells (Fig. 2A). WT cells were released from 
checkpoint arrest 4-6 h after 1.3 Gy and 12 h after 6 Gy X-irradiation. Significantly, Artemis 
cells were released slightly later after 1.3 Gy and failed to be released for at least 16 h after 6 
Gy (Fig. 2A and Suppl. Fig. 2B). Normal checkpoint induction and a prolonged arrest at the 
G2/M border was also observed in irradiated Artemis MEFs compared with WT MEFs (Fig. 
2B). We also evaluated the time course for the progression of G2 cells through mitosis into 
G1 by analysing BrdU-labeled cells. Exponentially growing fibroblasts were pulse-labeled 
with BrdU for 1 h and irradiated with 1 Gy 4 h after labeling (when in G2). G2/M checkpoint 
arrest results in the retention of BrdU-labeled cells in G2. Quantification of the BrdU-labeled 
G2 cells for up to 12 h post irradiation confirmed that Artemis cells exhibit a prolonged G2/M 
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arrest (Fig. 2C). The prolonged arrest of Artemis cells in Fig. 2 was less evident in the 
experiments involving mitotic counting (Suppl. Fig. 2A), which may reflect the use of 
nocodozole in the latter approach which delays re-entry from G2/M arrest. Our observation of 
a prolonged arrest in Artemis cells is consistent with a role of Artemis in DSB repair in G1 
and G2. One explanation for the difference between our results and those of Zhang et al. 
(2004) is that their study utilised human tumour cells for siRNA knock down of Artemis. 
Such cells frequently behave aberrantly due to abnormal levels of Chk1/Chk2 or cell cycle 
checkpoint regulation. 
 
ATM’s G2 checkpoint and repair functions both contribute to the avoidance of 
chromosome breakage 
Having established that Artemis affects ATM’s role in G2 DSB repair but not its function in 
G2 checkpoint control, we wished to evaluate the contribution of these two ATM functions to 
the prevention of chromosome aberrations in primary human WT, A-T and Artemis 
fibroblasts (Fig. 3). We focused on chromosome breaks arising from G2 irradiated cells by 
adding aphidicolin to prevent S-phase cells from progressing into G2 during analysis. 
Growing cell populations were irradiated with 1 Gy and analysed for chromosome breaks per 
mitotic cell at early times (2 and 4 h) post IR, similar to that undertaken in previous studies 
(Kemp and Jeggo, 1986). In all cell lines, chromosome breaks decreased with time reflecting 
DSB repair (Figs. 3A and B). A-T cells show a pronounced elevation of the number of 
chromosome breaks per mitotic cell (~3-fold higher than WT cells) whilst Artemis cells 
exhibit about two-fold more breaks/cell than WT cells consistent with Artemis’ repair 
function in G2 (Fig. 3A). Thus, a combined checkpoint and repair defect is more severe than a 
repair defect alone. 
We also evaluated the contribution of repair and checkpoint loss to chromosome 
aberration formation by utilizing the checkpoint inhibitor SB218078. This drug has been 
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described to impact upon Chk1 activity (Zhao et al., 2002) and abolishes 53BP1 foci 
formation after hydroxyurea treatment, a Chk1 dependent phenotype (Suppl. Fig. 3A) 
(Sengupta et al., 2004). Addition of SB218078 completely abolished the G2/M checkpoint 
response in primary human fibroblasts as well as in MEFs (Suppl. Fig. 3B and C) whilst 
repair of IR-induced DSBs in G2 remained unaffected (Suppl. Fig. 3D). SB218078 had no 
effect on chromosome aberration formation in A-T cells but increased the level of 
chromosome breaks/cell in Artemis cells to that of A-T cells (Fig. 3B). WT cells treated with 
SB218078 showed considerably fewer breaks/cell than drug-treated A-T or Artemis cells 
which represents the contribution of ATM/Artemis-dependent DSB repair to the prevention of 
chromosome aberrations in the absence of checkpoints. It is noteworthy that the cells forming 
chromosome aberrations are those in G2 at the time of irradiation as the addition of 
aphidicolin prevented S phase cells from progressing into G2 during analysis. Thus, any role 
of Chk1 in replication fork stability will not affect chromosome aberration formation. 
Moreover, SB218078 did not cause chromosome breaks in the absence of IR. 
 
Cells released from the G2/M checkpoint exhibit chromosome aberrations in mitosis 
Our studies predict that 1 Gy irradiated G2 phase Artemis cells would harbour 9-12 DSBs that 
remain unrepaired for prolonged times (see below). The release of Artemis cells from G2/M 
checkpoint arrest 6-8 h after irradiation suggested that the G2/M checkpoint might be unable 
to detect 9-12 DSBs. To investigate whether DSB repair is complete at the point of 
checkpoint release, we evaluated chromosome aberrations in mitotic cells that arise following 
checkpoint release (ie at time points greater than 4 h post IR) (Fig. 3). Since WT and Artemis 
cells progress from G2 into G1 within 12 h post IR with 1 Gy (see Fig. 2C), we evaluated 
chromosome breakage up to this time point. Strikingly, the level of chromosome aberrations 
in WT and Artemis cells at times when the cells that had initiated the checkpoint leave G2 (4-
8 h in WT and 6-10 h in Artemis) is about 1 to 2 breaks per cell (Fig. 3A), which is more than 
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10-fold above the background number of chromosome breaks. Thus, almost all cells released 
from the G2 checkpoint exhibit chromosome aberrations in mitosis. This observation 
represents direct experimental evidence that the human G2/M checkpoint is not maintained 
until the completion of repair. 
This prompted us to investigate the time course for the appearance of chromosome 
aberrations in mitosis. Cells entering mitosis at early times exhibit more chromosome breaks 
than cells entering at later times (Fig 3A). However, this analysis fails to consider the number 
of cells reaching mitosis at each time point. Thus, we assessed the number of cells reaching 
mitosis under the same conditions used for our chromosomal studies (ie in the presence of 
aphidicolin) by using phosphoH3 FACS analysis (Fig. 3C) and estimated the total number of 
mitotic chromosome breaks by multiplying the chromosome breaks per cell by the number of 
mitotic cells (Fig. 3D; see supplemental text for details of this estimation). Considering this 
novel concept, we examined the kinetics for mitotic chromosome breakage and observed a 
maximum at times after the G2/M checkpoint has been released (ie at 6-8 h in WT and at 8-10 
h in Artemis cells). Thus, cells released from the checkpoint (at >6 h post IR) as opposed to 
cells which escape checkpoint arrest at early times (at <4 h post IR) represent a major cause 
of mitotic chromosome breakage (Fig. 3D). We also evaluated the number of cells reaching 
mitosis from the progression of BrdU-labeled G2 cells (obtained from Fig. 2C). An estimation 
of the kinetics for mitotic chromosome breakage using this analysis provided similar results to 
that utilizing the phosphoH3 FACS data (Suppl. Fig. 3E). Thus, the concept of evaluating 
chromosome breakage by considering breaks per mitotic cell as well as the number of mitotic 
cells reveals the striking finding that checkpoint release prior to the completion of repair 
represents a major cause for chromosome aberration formation. Remarkably, the total number 
of breaks in released cells is similar in WT and Artemis cells, although they arise with 
delayed kinetics in the repair defective cells. The decrease in breaks at prolonged times post 
treatment (>10 h) is due to the depletion of irradiated G2 cells, ie nearly all cells have left G2. 
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A-T cells display entirely different kinetics. Due to the lack of checkpoint arrest, they display 
an elevated number of chromosome breaks that decreases with time in part due to DSB repair 
and due to the rapid depletion of the G2 population. 
 
The G2/M checkpoint has a defined threshold 
Our findings above establish that all cells released from the G2 checkpoint harbour unrepaired 
damage, strongly suggesting that the G2/M checkpoint has a threshold. Our observation that 
Artemis cells remain checkpoint arrested longer than WT cells (Fig. 2) but are released with a 
similar number of gH2AX foci (Fig. 1A) or mitotic chromosome breaks (Fig. 3A) supports 
this notion. However, we sought other procedures to confirm the presence of DSBs in G2 at 
the time of checkpoint release and to evaluate the sensitivity limit of the G2 checkpoint. As 
one approach, we performed premature chromosome condensation (PCC) of G2 cells using 
the phosphatase inhibitor calyculin A (Fig. 4A). G2 cells are readily distinguished from 
mitotic cells and allow the analysis of PCC breaks (Asakawa and Gotoh, 1997). At 4 and 6 h 
post 1 Gy X-irradiation, the time at which checkpoint release commences in WT and Artemis 
cells respectively, we observed 3-4 PCC breaks per cell consolidating the presence of DSBs at 
the time of checkpoint release (Fig. 4A). Moreover, WT cells at 4 h and Artemis cells at 6 h, 
harbour a similar number of PCC breaks. Interestingly, these studies also provide an 
additional demonstration of a repair defect in Artemis cells. Previous studies equating PCC 
breaks with DSBs estimated by PFGE have reported a 1:3-6 relationship (ie 3-6 DSBs equate 
to 1 PCC break) (Cornforth and Bedford, 1993). Thus, our PCC data suggest a sensitivity 
level of 10-20 DSBs. 
We also utilized gH2AX foci as a further marker to determine whether DSB repair is 
complete at the time of checkpoint release. We scored the number of foci in CENP-F positive 
G2-phase cells at differing times post IR and, in the same population of cells, counted the 
number of mitotic cells (Fig. 4B). We utilised exponentially growing transformed human 
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fibroblasts which provide a high mitotic index (MI). Mitotic cells were scored as phosphoH3 
positive cells with condensed chromatin. Consistent with the findings above, we observed that 
checkpoint duration increases with dose and that cells are released from the checkpoint with 
~20 foci (Fig. 4B). Similar results were obtained with hTert immortalised fibroblasts (data not 
shown). We also analysed mitotic cells at the 6 and 8 h time points and observed foci numbers 
similar to those of G2 cells demonstrating that the cells released from the checkpoint do enter 
mitosis with foci and that there is no selection for cells exiting the checkpoint (Suppl. Fig. 
3F). Previously, we and others have observed a 1:1 relationship between gH2AX foci and 
DSBs (Rogakou et al., 1999; Redon et al., 2002; Rothkamm and Löbrich, 2003; Rothkamm et 
al., 2003). Although it is possible that gH2AX foci analysis could over-estimate DSBs 
remaining if repair is completed prior to the loss of visible foci, this is unlikely to occur in 
Artemis deficient cells, where unrepaired DSBs persist for many days in G1 and G2. Thus, 
our studies analysing gH2AX foci are consistent with a threshold of 10-20 DSBs. 
Additionally, our PFGE studies with G2 (Fig. 1C) and previously with G0 cells show that 
~15% of the induced DSBs remain unrepaired in Artemis cells for many days. PFGE studies 
estimated 30-40 DSBs induced per Gy in G1 (Cedervall et al., 1995; Löbrich et al., 1995). 
Since G2 Artemis cells irradiated with 1 Gy are completely released from G2 by 12 h, the 
estimated persisting damage level (15% of 60-80 DSBs induced: 9-12 DSBs) is unable to 
maintain the checkpoint. In contrast, after 6 Gy, the level of DSBs remaining exceeds the 
threshold and results in arrest being maintained for at least 16 h. Hence, our PFGE data, 
which do not rely on gH2AX foci analysis, also indicate that the G2/M checkpoint threshold 
is greater than 9-12 DSBs. 
 To evaluate whether induction of the G2/M checkpoint has a similar sensitivity limit, 
we analysed transformed and immortalised fibroblasts exposed to doses up to 2 Gy at 2 h post 
irradiation, the earliest time point at which we observed complete arrest in pilot experiments 
(Fig. 4C). Cells irradiated with 0.6 Gy or higher show complete checkpoint arrest. 
 12
Significantly, the foci level 2 h after 0.6 Gy is about 20. Lower levels cause a partial arrest 
(Fig. 4C). Since repair occurs during the 2 h incubation necessary to measure checkpoint 
induction, our findings are consistent with a level of ~20 foci being required to activate 
checkpoint arrest. We also considered it important to examine primary human cells. The low 
MI of primary cells necessitated FACS analysis to estimate MI, precluding a parallel 
evaluation of gH2AX foci formation. Our findings were similar to those obtained using 
transformed/immortalised cells (Fig. 4C). Importantly, use of a lower dose inducing less than 
10 gH2AX foci did not induce any detectable arrest. Based on 30-40 DSBs induced per Gy in 
G1, 20 DSBs are induced after doses of 0.25-0.33 Gy in G2 cells. This correlates with the 
mild checkpoint induction observed here after 0.2-0.3 Gy and the absence of checkpoint arrest 
after 0.1 Gy (Fig. 4C). Thus, these findings are consistent with a similar threshold number of 
DSBs (10-20) both activating and maintaining checkpoint arrest. The existence of a threshold 
for G2/M checkpoint arrest provides a potential explanation for low dose hypersensitivity, a 
phenomenon describing exquisite cellular sensitivity at low radiation doses (Marples et al., 
2004). Indeed, a G2/M threshold of ~20 DSBs would predict the reported survival responses. 
In conclusion, we have examined the efficacy of ATM’s repair and checkpoint 
functions in G2, and dissected the contribution of these two ATM functions to the avoidance 
of chromosomal breakage. We demonstrate that (i) the kinetics of DSB repair in G2 is similar 
to that in G1 and that A-T and Artemis cells display an identical and epistatic repair defect in 
G2 as in G1; (ii) Artemis cells are G2/M checkpoint proficient; (iii) chromosome breaks occur 
0-4 h post IR in a small fraction of cells that fail to arrest at the G2/M checkpoint; (iv) the 
majority of cells arrest at the G2/M checkpoint but give rise to 1-2 chromosome breaks upon 
release. This represents a major cause of chromosome aberration formation. (v) The G2/M 
checkpoint has a defined threshold which we estimate to be ~3-4 PCC breaks or ~10-20 
DSBs. This threshold allows for the generation of 1-2 chromosome breaks in mitosis. 
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Materials and methods 
Cell culture, chemicals, and irradiation 
Cells were grown as described (Riballo et al., 2004). 10, 15 or 20 % FCS was used depending 
on the cell line. For the FAR assay, cells were labeled with 37 kBq/ml [methyl-3H]Thymidine 
(2,81 TBq/mmol; Amersham) for 1 h (electrophoresis was performed according to Kühne et 
al. (2004)). Aphidicolin and nocodazole (Sigma) were added at 3 µg/ml and 100 ng/ml, 
respectively. Inhibition of Chk1 activity was achieved by addition of SB218078 (2.5 µM; 
Calbiochem) 30 min prior to IR. ATMi (KU55933) was added at 10 mM 30 min prior to IR. 
X-irradiation was performed at 90 kV or 120 kV, g-irradiation using a 137Cs- source. 
Dosimetry was performed with ion chambers and considered the increase in dose for cells 
grown on glass coverslips relative to plastic surfaces (manuscript in preparation). 
 
Metaphase spreads and PCC 
To collect metaphases, 100 ng/ml colcemid (Sigma) was added 2 h before harvesting (1 h for 
the 2 h time point and 4 h for the 12 h time point). For PCC analysis, cells were treated with 
50 ng/ml calyculin A (Calbiochem) for 30 min before harvesting. Chromatid breaks and 
excess fragments (counted as 2 chromatid breaks) were scored in 20-100 chromosome spreads 
from at least three independent experiments per data point. 
 
FACS 
Cells pulse-labeled with 10 µM BrdU (Roche) for 1 h were analysed according to standard 
protocols. For phosphoH3 staining, cells were permeabilised with PBS/0.25% Triton X-100 
(15 min on ice), incubated in 100 µl a-phosphoH3 antibody (Ser10) (7.5 µg/ml PBS/1% 
BSA) (Upstate) over night, then treated with the Alexa Fluor 488-conjugated goat-a-mouse 
(MoBiTec) or a FITC-conjugated swine a-rabbit antibody (DakoCytomation) in PBS/1% 
BSA for 1 h, followed by 50 µg/ml propidium iodide containing 0.5 mg/ml RNAse in PBS for 
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30 min at room temperature. Analysis was performed on a FACScanTM or FACSCaliburTM 
using the CellQuest software (Becton Dickinson). 
 
Immunofluorescence 
Cells grown on coverslips were fixed in 100% methanol (-20°C) for 30 min, permeabilised in 
acetone (-20°C) for 1 min and washed 3x10 min in PBS/1% FCS. Samples were incubated 
with primary antibodies (monoclonal or polyclonal a-gH2AX antibody 1:200; Upstate; 
polyclonal a-CENP-F and a-CyclinA antibody 1:200; Santa Cruz; or polyclonal a-
phosphoH3 antibody (Ser10) 1:200, Upstate) in PBS/1% FCS for 1 h at room temperature, 
washed in PBS/1% FCS for 3x10 min, and incubated with Alexa Fluor 488-, Alexa Fluor 546- 
or Alexa Fluor 594-conjugated secondary antibodies (MoBiTec, 1:500) for 1 h at room 
temperature. Cells were washed in PBS for 4x10 min and mounted using Vectashield 
mounting medium containing 4,6 diamidino-2-phenylindole (Vector Laboratories, 
Burlingame, CA). In a single experiment, cell counting was performed until at least 40 cells 
and 40 foci were registered per sample. Each data point represents two to three independent 
experiments. Error bars represent the SE between the different experiments. 
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A-T, ataxia telangiectasia 
ATM, ataxia telangiectasia mutated 
CENP, centromere protein 
DSB, double-strand break 
FAR, fraction of radioactivity released 
MI, mitotic index 
PCC, premature chromosome condensation 
PFGE, pulsed-field gel electrophoresis 
MEF, mouse embryo fibroblast 
WT, wild type 
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Figure 1: 
 
 
 
Figure 1. A-T and Artemis primary human fibroblasts exhibit a DSB repair defect in G1 and 
G2. (A) gH2AX foci analysis in G1- and G2-phase cells following 1.5 Gy X-irradiation. 
Background foci numbers were about 2 in G2 and 0.2 in G1. (B) gH2AX foci analysis in G1- 
and G2-phase cells following 1.5 Gy X-irradiation in the absence or presence of the ATM 
small molecule inhibitor KU55933 (ATMi). (C) FAR assay of [methyl-3H]thymidine-labeled 
exponentially growing cells irradiated in G2. Left panel: Ethidium bromide-stained PFGE gel 
from primary human fibroblasts irradiated with 10 Gy (for assessing DSB induction) or 80 Gy 
(for 48 h and 72 h repair points) X-rays. Right panel: FAR values calculated from the 
scintillation counts of gel slices derived from PFGE gels. 
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Figure 2: 
 
 
 
Figure 2. Artemis cells show proficient checkpoint induction and a prolonged G2/M arrest. 
(A) phosphoH3 analysis of primary human fibroblasts following 1.3 and 6 Gy X-irradiation. 
(B) phosphoH3 analysis of MEFs following 3 Gy g-irradiation. Data shown are the percentage 
of mitotic cells relative to unirradiated cells at time zero. (C) FACS analysis of BrdU-labeled 
primary human fibroblasts. The percentage of BrdU-positive cells in late S/G2 was assessed 
up to 8 h after 1.5 Gy X-irradiation given at 4 h post BrdU labeling (ie when BrdU-labeled 
cells have progressed into late S/G2). Dotted lines represent the percentage of BrdU-positive 
cells in late S/G2 without irradiation. 
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Figure 3: 
 
 
 
Figure 3. ATM’s repair and checkpoint functions contribute to prevent chromosome 
breakage. (A) Chromosome breaks per mitotic cell in metaphase spreads from primary human 
fibroblasts harvested at varying times following 1 Gy X-irradiation in the presence of 
aphidicolin. Breaks in unirradiated samples were less than 0.1 and were subtracted from the 
breaks in the irradiated samples. (B) Same analysis as in panel A in the presence of the 
Chk1/2 inhibitor SB218078. SB218078 did not cause chromosome breaks in unirradiated 
cells. (C) phosphoH3 analysis of primary human fibroblasts after 1 Gy X-irradiation in the 
presence of aphidicolin (ie the same conditions used for the chromosomal analysis). The 
measured mitotic indices were normalised to provide the same integral value of 1 for all three 
cell lines. (D) Estimation of the kinetics for total mitotic chromosome breakage. The values 
are derived from the number of chromosome breaks per mitotic cell for cells that enter mitosis 
at specific time points (taken from panel A) multiplied by the number of cells reaching 
mitosis at these times (taken from panel C). See supplemental text for a more detailed 
description of panels C and D. 
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Figure 4: 
 
 
 
Figure 4. The G2/M checkpoint has a threshold of ~3.5 PCC breaks and ~20 gH2AX foci. (A) 
Analysis of G2 PCC chromosomal breaks in calyculin A-treated cells in the presence of 
aphidicolin at 2, 4, and 6 h after 1 Gy X-irradiation. Breaks in unirradiated samples were less 
than 0.2 and were subtracted from the breaks in the irradiated samples. Student’s t-test was 
performed: P<0.01 for AT1BR, AT7BI, CJ179, and F01-204 compared with HSF1 or C2906 
at 4 and 6 h (but not at 2 h). (B) gH2AX analysis and mitotic counting of transformed MRC-
5V1 fibroblasts at varying times after 1, 2, and 10 Gy X-irradiation in the presence of 
aphidicolin. The analysis was done on the same samples by counting the fraction of 
phosphoH3 positive mitotic cells and foci numbers in CENP-F positive G2 cells, respectively. 
The pronounced decline in mitotic index at 8 h after 1 and 2 Gy likely reflects the depletion of 
G2 cells. (C) Left panel: same analysis as in panel B evaluating transformed (MRC-5V1; grey 
bars, diamonds) and immortalised (48BR hTert; shaded bars, squares) fibroblasts 2 h after 0, 
0.2, 0.6, 1, and 2 Gy X-irradiation. Right panel: phosphoH3 analysis of primary (48BR) 
fibroblasts after 0, 0.1, 0.3, 0.5, and 1 Gy X-irradiation by FACS. gH2AX foci were scored on 
parallel samples and provided similar numbers to those of MRC-5V1 and 48BR hTert cells. 
Analysis was carried out 1 h post IR, since pilot experiments showed that primary cells show 
a more rapid onset of checkpoint arrest. Note that very short exposure times were required to 
deliver the low doses in these experiments, resulting in potential errors in the estimated 
dosimetry. 
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Supplemental figure legends 
Suppl. Figure 1. (A) Representative immunofluorescence images of exponentially growing 
HSF1 cells irradiated with 1.5 Gy X-rays in the presence of aphidicolin. Treatment with 
aphidicolin resulted in high levels of gH2AX phosphorylation in a subset of the cells (a bright 
lawn-like signal as shown in the lower left panel). Double staining against gH2AX and 
CyclinA showed that all gH2AX-positive cells were positive for the S/G2 marker CyclinA. 
Double staining against gH2AX and CENP-F showed that all gH2AX-positive cells were 
negative for the G2 marker CENP-F. Since this gH2AX signal was observed without 
irradiation and was dependent on aphidicolin, we attribute it to the activation of ATR 
following replication arrest caused by aphidicolin. Hence, double staining against 
gH2AX/CENP-F allows the unequivocal identification of G1 (gH2AX and CENP-F negative), 
S (gH2AX positive and CENP-F negative), and G2 cells (gH2AX negative and CENP-F 
positive). (B) Representative FACS plots of HSF1 cells in the presence of aphidicolin 
following a dose of 1 Gy X-rays. Cells were BrdU labeled for 1 h, irradiated immediately 
after labeling and aphidicolin was added. The upper rectangles show the percentages of BrdU-
positive cells in early versus late S phase. The lower rectangle indicates the percentage of 
BrdU-negative cells in G2. (C) gH2AX analysis in the presence or absence of aphidicolin in 
G2-phase MRC-5 cells. (D) gH2AX analysis in exponentially growing MEFs. The analysis 
was carried out in the presence of aphidicolin (similar to Fig. 1). (E) Representative FACS 
plots showing the percentage of BrdU-labeled primary human fibroblasts in G2 at 0, 48, and 
72 h after 80 Gy X-irradiation (rectangles). Irradiation was performed 4 h after BrdU labeling. 
 
Suppl. Figure 2. (A) G2/M checkpoint analysis by mitotic counting. The mitotic index was 
assessed in primary human fibroblasts at 8, 16, and 24 h after 3 and 6 Gy g-irradiation. 
Nocodazole was added immediately following irradiation to accumulate cells in mitosis. (B) 
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Representative FACS plots of primary human fibroblasts showing mitotic cells (circles) 
identified by phosphoH3 staining after 1.3 and 6 Gy X-irradiation. No nocodazole was used 
for these experiments. 
 
Suppl. Figure 3. (A) 53BP1 foci formation in transformed human WT fibroblasts treated 
with Chk1 siRNA or the Chk1 inhibitor SB218078 after exposure to 1 mM hydroxyurea for 2 
h (for technical details see Stiff et al., 2006, EMBO J 25: 5775-5782). (B) phosphoH3 
analysis in primary human fibroblasts at 1, 4, and 8 h after 1 Gy X-irradiation in the presence 
of the Chk1/2 inhibitor SB218078. (C) phosphoH3 analysis of WT MEFs at 1, 2, 4, and 6 h 
after 3 Gy g-irradiation with or without SB218078. Data are shown as the percentage of 
mitotic cells relative to untreated and unirradiated cells at time zero. (D) gH2AX analysis in 
G2-phase primary human fibroblasts (HSF1) in the presence or absence of SB218078 at 2, 4, 
6, and 8 h after 1.5 Gy X-irradiation. (E) Estimation of the kinetics for total mitotic 
chromosome breakage. The values are derived from the number of chromosome breaks per 
mitotic cell for cells that enter mitosis at specific time points (taken from Fig. 3A) multiplied 
by the number of cells reaching mitosis at these times (calculated from Fig. 2C from the 
decrease in the fraction of late S/G2 cells). For example: Artemis cells exhibit ~1.5 breaks per 
mitotic cell at 8 h post IR (Fig. 3A). Between 6 and 8 h, the fraction of BrdU-positive Artemis 
cells in late S/G2 decreases from ~90% to ~70%, ie ~20% of the irradiated G2 cells have 
entered mitosis between 6 and 8 h (Fig. 2C). Thus, we multiplied the value of 1.5 by 0.2 (to 
account for the fraction of G2 cells entering mitosis) and by 1000 (to normalise it to 1000 
irradiated G2 cells). Thus, we obtained a value of ~300 total mitotic breaks for Artemis cells 
in the time window 6-8 h. This number means that 1000 irradiated G2-phase Artemis cells 
give rise to ~300 mitotic breaks in the time period between 6 and 8 h post IR with 1 Gy (the 
12-h data points in Fig. 3A were taken to calculate total break numbers in the time windows 
8-10 h and 10-12 h). (F) gH2AX analysis in mitotic human fibroblasts (hTert WT cells) at 6 h 
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after 1 Gy X-irradiation. The analysis was carried out in the presence of aphidicolin under 
checkpoint-proficient conditions (ie without SB218078). The phosphoH3 positive cells 
represent cells in different stages of mitosis. The average foci number in phosphoH3 positive 
cells at the 6 h time point was 12, similar to the foci number of 14 obtained in a parallel 
sample from the analysis of CENP-F positive G2 cells. 
 
Supplemental text 
Estimation of the kinetics for total chromosome breakage 
Fig. 3D aims to compare the time course for total mitotic chromosome breakage for three 
different cell lines; A-T, Artemis and WT. We have measured for all three lines the mitotic 
index at defined times post irradiation by phosphoH3 FACS analysis under the same 
conditions used for the chromosomal analysis, ie in the presence of aphidicolin (Fig. 3C). 
However, different cell lines can vary considerably in their fraction of G2 phase cells. 
Moreover, the majority but not all G2-irradiated cells leave G2 within 12 h with slight 
differences between the three cell lines (see Fig. 2C). We have considered the first variation 
(different G2 proportions) by normalising the phosphoH3 data in Fig. 3C such that the sum of 
the mitotic indices measured up to 12 h post irradiation is the same for all three cell lines and 
the second variation by multiplying these mitotic indices with the measured proportion of G2-
irradiated cells that leave G2 within 12 h. The latter values are derived from Fig. 2C. For 
example: Artemis cells entering mitosis at 8 h post IR exhibit ~1.5 breaks per mitotic cell 
(Fig. 3A). At this time, the relative mitotic index for Artemis cells is about 0.35. Thus, we 
multiplied the value of 1.5 by 1000 (to normalise it to 1000 irradiated G2 cells), then by 0.75 
(because 75% of all irradiated G2 Artemis cells leave G2 within 12 h, see Fig. 2C), and 
finally by 0.35 (because 35% of all cells that leave G2 within 12 h do this at the 8 h time 
point). This provides a value of ~400 mitotic breaks for Artemis cells at 8 h (Fig. 3D). 
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